Rebaudioside A/TPGS mixed nanomicelles as promising nanocarriers for nimodipine ocular delivery
The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Nimodipine (NMD), a calcium channel blocker, has demonstrated benefits in treating glaucoma. However, its ocular therapeutic application remains limited due to its poor aqueous solubility, which restrains the development of an ophthalmic formulation. Thus, the present study aimed to formulate an NMD micelle ophthalmic solution to enhance the potential of NMD in an ocular topical formulation to treat glaucoma. The NMD micelle ophthalmic solution was formulated with nanocarriers composed of rebaudioside A and D-α-tocopheryl polyethylene glycol 1000 succinate. Spherical mixed micelles were optimized and obtained at a small micelle size 13.429 ± 0.181 nm with a narrow size distribution (polydispersity index 0.166 ± 0.023) and high encapsulation efficiency rate (99.59 ± 0.09%). Compared with free NMD, NMD in micelles had much greater in vitro membrane permeability and antioxidant activity. The NMD micelle ophthalmic solution was well tolerated in rabbit eyes. It profoundly improved the in vivo intraocular permeation of NMD, and in vivo intraocular pressure reduction and improved miosis were also observed. Accordingly, this NMD micelle ophthalmic solution might be a promising ocular formulation to treat glaucoma. Graphical abstract.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Compared with free NMD, micellar formulations presented significantly enhanced membrane permeability and antioxidant activity in vitro [158].”
From From design to Deployment: The innovative role of nanomicelles in targeted ophthalmic therapeutics (2025) · cites this paper as [158]
In the citing paper
“The NMD micelle ophthalmic solution corroborated favorable tolerance in rabbit eyes, with abatement in IOP and ameliorated miosis in vivo.”
From From design to Deployment: The innovative role of nanomicelles in targeted ophthalmic therapeutics (2025) · cites this paper as [158]
Citations
Cites
The applications of Vitamin E TPGS in drug delivery
Guo, Y., Luo, J., Tan, S., Otieno, B. O., & Zhang, Z. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.02.006 · Cited by 523
Glaucoma treatment trends: a review
Conlon, R., Saheb, H., & Ahmed, I. I. K. (2017) · Canadian Journal of Ophthalmology · doi:10.1016/j.jcjo.2016.07.013 · Cited by 344
Glaucoma: the retina and beyond
Davis, B. M., Crawley, L., Pahlitzsch, M., Javaid, F., & Cordeiro, M. F. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1609-2 · Cited by 281
Development of rebiana, a natural, non-caloric sweetener
Prakash, I., DuBois, G. E., Clos, J. F., Wilkens, K. L., & Fosdick, L. E. (2008) · Food and Chemical Toxicology · doi:10.1016/j.fct.2008.05.004 · Cited by 234
Glaucoma: Current treatment and impact of advanced drug delivery systems
Yadav, K. S., Rajpurohit, R., & Sharma, S. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.02.029 · Cited by 176
Antioxidant activity of selected phenols estimated by ABTS and FRAP methods
Biskup, I., Golonka, I., Gamian, A., & Sroka, Z. (2013) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.5604/17322693.1066062 · Cited by 142
Zhang, P., Liu, X., Hu, W., Bai, Y., & Zhang, L. (2016) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2016.04.115 · Cited by 138
Poloxamer 407/TPGS mixed micelles as promising carriers for cyclosporine ocular delivery
Grimaudo, M. A., Pescina, S., Padula, C., Santi, P., Concheiro, A., Alvarez-Lorenzo, C., & Nicoli, S. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00939 · Cited by 138
Fabrication of a Micellar Supramolecular Hydrogel for Ocular Drug Delivery
Zhang, Z., He, Z., Liang, R., Ma, Y., Huang, W., Jiang, R., Shi, S., Chen, H., & Li, X. (2016) · Biomacromolecules · doi:10.1021/acs.biomac.5b01526 · Cited by 129
Self-citationBonniard, A. A., Yeung, J. Y. T., Chan, C. C., & Birt, C. M. (2016) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2016.1209481 · Cited by 118
Cited by
Han, H., Li, S., Xu, M., Zhong, Y., Fan, W., Xu, J., Zhou, T., Ji, J., Ye, J., & Yao, K. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114770 · Cited by 322
Overview of Recent Advances in Nano-Based Ocular Drug Delivery
Liu, L.-C., Chen, Y., & Lu, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015352 · Cited by 172
The use of TPGS in drug delivery systems to overcome biological barriers
Luiz, M. T., Filippo, L. D. D., Alves, R. C., Araújo, V. H. S., Duarte, J. L., Marchetti, J. M., & Chorilli, M. (2020) · European Polymer Journal · doi:10.1016/j.eurpolymj.2020.110129 · Cited by 126
Chandel, A., & Kandav, G. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105785 · Cited by 49
Recent development of polymer nanomicelles in the treatment of eye diseases
Cai, R., Zhang, L., & Hao, C. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1246974 · Cited by 43
Metadata
- Authors
- Li, X., Fang, J., Xin, M., Li, Q., Wang, J., Yang, H., & Wu, X.
- Affiliations
- Qingdao University of Science and Technology (CN)
- Qingdao University (CN)
- Binzhou Medical University (CN)
- Corresponding author
- Wu, Xianggen
- Venue
- Drug Delivery and Translational Research
- Published
- 2020-08-11
- Volume
- 11
- Issue
- 3
- Pages
- 1119-1132
- ISSN
- 2190-393X (ISSN-L)
- 2190-3948
- OpenAlex
- W3048481911
- Cited by
- 27
- References
- 57
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 7 · 2023: 9 · 2022: 3 · 2021: 1 · 2020: 1
- FWCI
- 1.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Drug Delivery and Translational Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81770895)
- Key Technology Research and Development Program of Shandong (2019GSF108027)
- Talent Fund of Shandong Collaborative Innovation Center of Eco-Chemical Engineering (XTCXQN19)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
- Keywords
- nimodipine, rebaudioside A, TPGS, mixed micelles, ocular drug delivery, glaucoma, calcium channel blockers, ophthalmic preparations, intraocular pressure, miosis, membrane permeability, antioxidant activity, ocular tolerance
- MeSH terms
- Animals, Cornea, Drug Carriers, Micelles, Nimodipine, Polyethylene Glycols, Rabbits, Vitamin E, Diterpenes, Kaurane, Administration, Ophthalmic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Rebaudioside A/TPGS mixed nanomicelles as promising nanocarriers for nimodipine ocular delivery. https://app.cochat.ai/papers/10.1007/s13346-020-00834-0
- The paper
- Li, X., Fang, J., Xin, M., Li, Q., Wang, J., Yang, H., & Wu, X. (2021). Rebaudioside A/TPGS mixed nanomicelles as promising nanocarriers for nimodipine ocular delivery. Drug Delivery and Translational Research. https://doi.org/10.1007/s13346-020-00834-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.